Background Image
Table of Contents Table of Contents
Previous Page  2 / 76 Next Page
Information
Show Menu
Previous Page 2 / 76 Next Page
Page Background

Pharma Dynamics Clopidogrel 75 mg.

Each film coated tablet contains clopidogrel hydrogen sulphate equivalent to clopidogrel 75 mg. Reg. No.: RSA S3 42/8.2/0128. NAM NS2 10/7.1/0377. For full prescribing information, refer

to the package insert approved by the Medicines Control Council, October 2008.

1)

Vs originator clopidogrel. Department of Health website

http://www.doh.gov.za

– Accessed 09/04/2015.

2)

Poponina TM,

et al.

Current approaches

to the prevention of thrombotic complications in patients with acute coronary syndrome without ST-segment elevation. Topical issues of heart and vascular diseases. 2009;4:4-9. (English translation)

3)

Creager MA. Results of the

CAPRIE trial: efficacy and safety of clopidogrel.Vascular Medicine 1998;3:257-260.

4)

COMMIT Collaborative Group.Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled

trial. The Lancet 2005;366(9497):1607-1621.

5)

Sabatine MS,

et al.

Addition of Clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New England Journal of Medicine 2005;352:1179-

89.

6)

The CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine 2001;345:494-502.

PDCLC203/06/2015

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Tel

021 707 7000

Fax

021 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

Shown to reduce the risk of atherosclerotic events

in a wide range of patients with a history of:

Stroke

3,4,6

PAD

3

STEMI

4,5

Unstable Angina/NSTEMI

6

cost e ective

1

,

clinically proven

2

reduction

of atherosclerotic events

A Lupin Group Company